About Omniactive Health Technologies Limited
Data last updated: 04 January 2026
Omniactive Health Technologies Limited is a public limited company based in Mumbai, Maharashtra, India, a subsidiary of Ta Oa Limited. It specialises in api manufacturers, a part of the broader pharmaceuticals sector. Incorporated on 27 August 2003, the company has been in operation for over 23 years.
Registered with ROC Mumbai under CIN U24230MH2003PTC141898.
Capital: an authorised share capital of ₹104.25 Cr and a paid-up capital of ₹11.74 Cr. Formerly known as Phyto-Actives (India) Private Limited and Omniactive Health Technologies Private Limited. It is led by directors including Milind Shripad Sarwate and Vishal Gupta.
Last AGM: 16 September 2025. Financial statements filed for year ended 31 March 2025. Office: Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹897.07 Cr, a growth of 6% compared to the previous year.
The company has a workforce of approximately 505 employees as per the latest available data. It operates as a subsidiary of Ta Oa Limited.
The company is associated with 2 brands - Omniactive, Setu. As per MCA filings, the company has open charges of ₹396.03 Cr and satisfied charges of ₹588.59 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website omniactives.com.
-
Email**************
-
Telephone**************
-
Website**************
-
Social Media**************
-
Registered AddressUnit No. T – 8B 5Th Floor Phoenix House Phoenix Mills Compound 462 S B Marg L, Ower Parel, Mumbai, Maharashtra, India – 400013
-
IndustryPharma, API Manufacturers
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Name History of Omniactive Health Technologies Limited
Omniactive Health Technologies Limited has undergone 2 name changes throughout its history. The company was previously known as Phyto-Actives (India) Private Limited, and Omniactive Health Technologies Private Limited. The current legal name is Omniactive Health Technologies Limited, reflecting the company's evolution and rebranding over time.
| Company Name | Status |
|---|---|
| Omniactive Health Technologies Limited | Current |
| Phyto-Actives (India) Private Limited | Previous |
| Omniactive Health Technologies Private Limited | Previous |
CIN History of Omniactive Health Technologies Limited
Omniactive Health Technologies Limited has one previous CIN (Corporate Identification Number): U24230MH2003PTC141898. The current CIN is U24230MH2003PLC141898, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230MH2003PLC141898 | Current |
| U24230MH2003PTC141898 | Previous |
Associated Brands with Omniactive Health Technologies Limited
Omniactive Health Technologies Limited operates two associated brands: OmniActive and Setu. These brands represent Omniactive Health Technologies Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Nutritional supplements for multiple health ailments are developed. | omniactives.com | |
| Dietary supplements with herbal extracts and vitamins are provided. | setu.in |
Competitors & Alternatives of Omniactive Health Technologies Limited
Brands and companies operating in the same space as Omniactive Health Technologies Limited include Kapiva, ChromaDex, LifeVantage and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Kapiva
|
Ayurvedic healthcare and nutritional products are provided by Kapiva. | Bengaluru, India, India | 2016 |
ChromaDex
|
Nutritional ingredients for health and wellness are developed. | Irvine, United States, United States | 1999 |
LifeVantage
|
Nutritional products for various health ailments are provided. | Monroe, United States, United States | 2003 |
Designs for Health
|
Dietary supplements and medical foods are provided for health professionals. | Suffield, United States, United States | 1989 |
Botanic Healthcare
|
Develops natural ingredients for use across health, food, ayurvedic botanical, and cosmetic industries | Hyderabad, India, India | 2013 |
Labomar
|
Dietary supplements, diet foods, health products, and medical devices | Treviso, Italy, Italy | 1998 |
BBetter
|
Nutritional supplements are provided to enhance health and wellness. | Hyderabad, India, India | 2018 |
Nemysis
|
Nano-particulate supplements are developed for iron deficiency and gluten intolerance. | Dublin, Ireland, Ireland | 2015 |
Berkem
|
Natural active ingredients are manufactured and marketed by Berkem. | Gardonne, France, France | 1993 |
Alpex Pharma
|
Contract research and manufacturing services are provided to pharmaceutical firms. | Mezzovico Vira, Switzerland, Switzerland | 2000 |
Business Activity of Omniactive Health Technologies Limited
Omniactive Health Technologies Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | ********* |
Board of Directors of Omniactive Health Technologies Limited
Omniactive Health Technologies Limited is currently managed by 7 directors, with 24 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Milind Shripad Sarwate
Also directs:
Increate Value Advisors Llp, Increate Social Value Advisors & Resourcers Llp, Asian Paints Limited and 5 more
|
Director | 30 Apr 2020 | 6 Years 2 Months | Current |
| Vishal Gupta | Nominee Director | 21 Jul 2022 | 3 Years 11 Months | Current |
| Rupa Rajul Vora | Director | 21 Jul 2022 | 3 Years 11 Months | Current |
| Leendert Hendrik Staal | Director | 12 Jan 2021 | 5 Years 5 Months | Current |
|
Dhiraj Poddar
Also directs:
Dough Hook Artisanal Bakery Llp, Synokem Pharmaceuticals Limited, Zifo Technologies Private Limited. and 3 more
|
Nominee Director | 07 Jan 2021 | 5 Years 6 Months | Current |
| Sanjay Jayasinh Mariwala | Managing Director | 16 Aug 2004 | 21 Years 10 Months | Current |
Financials of Omniactive Health Technologies Limited FY 2025 filings available
Omniactive Health Technologies Limited reported revenue of ₹897.07 Cr (up 6% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Charges & Borrowings of Omniactive Health Technologies Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Apr 2025 | Axis Bank Limited | ₹50 Cr | Open |
| 20 Jun 2022 | Others | ₹35 Cr | Open |
| 10 Aug 2021 | Others | ₹155 Cr | Open |
| 17 Apr 2020 | Hdfc Bank Limited | ₹75 Cr | Open |
| 11 Jul 2019 | Others | ₹1.03 Cr | Open |
Total charge records: 37 View all charges
Employees and EPFO Compliance at Omniactive Health Technologies Limited
View historical data on people associated with Omniactive Health Technologies Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Omniactive Health Technologies Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Omniactive Health Technologies Limited
GSTIN & GST Filing Data of Omniactive Health Technologies Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Omniactive Health Technologies Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Omniactive Health Technologies Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Omniactive Health Technologies Limited
MSME Payment Delays by Omniactive Health Technologies Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Omniactive Health Technologies Limited
Subsidiaries & Group Companies of Omniactive Health Technologies Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Omniactive Health Technologies Limited with ownership details.
MCA Filings & Documents of Omniactive Health Technologies Limited
MCA Filings & Documents of Omniactive Health Technologies Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Omniactive Health Technologies Limited
Recent News on Omniactive Health Technologies Limited
Frequently Asked Questions about Omniactive Health Technologies Limited
Omniactive Health Technologies Limited is an active public limited company in the pharma sector based in Mumbai, Maharashtra, India. It was incorporated on 27 August 2003 (23+ years old) and is registered under CIN U24230MH2003PLC141898. The company has 505 employees.
Omniactive Health Technologies Limited reported revenue of ₹897.07 Cr for FY 2025 (up 6.00% YoY).
The current directors of Omniactive Health Technologies Limited are:
The primary industry of Omniactive Health Technologies Limited is pharma. The company specifically operates in api manufacturers. The company is currently active in this sector.
Omniactive Health Technologies Limited can be reached at the registered office: Unit No. T – 8B 5Th Floor Phoenix House Phoenix Mills Compound 462 S B Marg L, Ower Parel, Mumbai, Maharashtra, India – 400013, or through the website omniactives.com.
The authorised capital is ₹104.25 Cr, and the paid-up capital is ₹11.74 Cr.